Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideLLYLilly (Eli)
FinDog View：Bullish
ABTAbbott Laboratories
FinDog View：Neutral
| Metric | LLY | ABT |
|---|
| Close | 1,137.82 | 102.36 |
| Market Cap | $1.07T | $177B |
| 1M | −3.83% | −7.26% |
| P/E (TTM) | 39.9 | 33.2 |
| Forward P/E | 28.5 | 18.1 |
| P/E 5-Yr Percentile | 6 | 66 |
| P/S | 13.4 | 3.9 |
| P/B | 31.5 | 3.5 |
| Dividend Yield | 0.75% | 1.98% |
| Latest Quarter Revenue | $23.0B | $11.2B |
| Revenue YoY | +47.7% | +7.8% |
| Gross Margin | 85.8% | 56.2% |
| Latest Quarter EPS | 7.94 | 0.61 |
| Avg Post-Earnings Move | ±3.5% | ±1.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.12% | 2.81% |
| 90-Day Net Insider Buying | −$16.0M | −$46.7M |
LLY · Revenue, Last 8 Quarters ($B)
ABT · Revenue, Last 8 Quarters ($B)
